BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21561860)

  • 21. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.
    Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
    Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.
    Jebahi A; Villedieu M; Pétigny-Lechartier C; Brotin E; Louis MH; Abeilard E; Giffard F; Guercio M; Briand M; Gauduchon P; Lheureux S; Poulain L
    Cancer Lett; 2014 Jun; 348(1-2):38-49. PubMed ID: 24650799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim.
    Sheridan C; Brumatti G; Martin SJ
    J Biol Chem; 2008 Aug; 283(32):22128-35. PubMed ID: 18508762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular signal-regulated kinase activation by Neisseria gonorrhoeae downregulates epithelial cell proapoptotic proteins Bad and Bim.
    Howie HL; Shiflett SL; So M
    Infect Immun; 2008 Jun; 76(6):2715-21. PubMed ID: 18391004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
    Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
    Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells.
    Stang SL; Lopez-Campistrous A; Song X; Dower NA; Blumberg PM; Wender PA; Stone JC
    Exp Hematol; 2009 Jan; 37(1):122-134. PubMed ID: 19100522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increase in BIK expression following ERK1/2 pathway inhibition is a consequence of G₁ cell-cycle arrest and not a direct effect on BIK protein stability.
    Sale MJ; Cook SJ
    Biochem J; 2014 May; 459(3):513-24. PubMed ID: 24527759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone demethylase Jmjd3 regulates osteoblast apoptosis through targeting anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bim.
    Yang D; Okamura H; Teramachi J; Haneji T
    Biochim Biophys Acta; 2016 Apr; 1863(4):650-9. PubMed ID: 26795455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
    O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
    J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
    Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
    Craxton A; Draves KE; Gruppi A; Clark EA
    J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line.
    Gordon PM; Fisher DE
    J Biol Chem; 2010 May; 285(19):14109-14. PubMed ID: 20231287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin.
    Dhar R; Basu A
    Int J Oncol; 2008 May; 32(5):1133-7. PubMed ID: 18425342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation and down-regulation of Bim by muscarinic cholinergic receptor activation via protein kinase C.
    Styles NA; Zhu W; Li X
    Neurochem Int; 2005 Dec; 47(8):519-27. PubMed ID: 16183168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
    Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
    Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
    Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.